"Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.
about
Molecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt SignallingRadiation-induced meningiomas in multiple regions, showing rapid recurrence and a high MIB 1 labeling index: a case report and review of the literatureTranscriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade.Increasing rates of brain tumours in the Swedish national inpatient register and the causes of death register.Increased phosphorylation of vimentin in noninfiltrative meningiomasMeningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO reviewMalignant Meningioma - Clinicopathological Study of an Unusual Presentation of a Rare Malignancy.Update on meningiomas.Diagnosis and treatment of atypical and anaplastic meningiomas: a review.The accuracy of meningioma grading: a 10-year retrospective audit.Rapidly enlarging chordoid meningioma with abundant mucin production.Imaging of meningioma progression by matrix-assisted laser desorption ionization time-of-flight mass spectrometryBone involvement predicts poor outcome in atypical meningioma.Genomic profiling of atypical meningiomas associates gain of 1q with poor clinical outcome.Atypical primary meningioma in the nasal septum with malignant transformation and distant metastasis.Immunohistochemical characterization of brain-invasive meningiomasDNA methylation in the malignant transformation of meningiomas.Gene expression profiles of metabolic aggressiveness and tumor recurrence in benign meningioma.Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.Molecular biological determinations of meningioma progression and recurrence.Dose-painting intensity-modulated proton therapy for intermediate- and high-risk meningiomaIntracranial meningioma with leptomeningeal dissemination : retrospective study with review of the literature.DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningiomaAlterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomasMolecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays.Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas.Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United StatesDevelopment of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1.The histopathological spectrum of human meningiomasPathology and molecular genetics of meningioma: recent advances.Meningioma: a clinicopathological evaluationCytology of chordoid meningioma: a series of five cases with emphasis on differential diagnosesInterinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification.Antigen expression on recurrent meningioma cells.Molecular signatures define two main classes of meningiomas.Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.Histopathological and Immunohistochemical Evaluation of Meningiomas with Reference to Proliferative Markers p53 and Ki-67.Update on Select Benign Mesenchymal and Meningothelial Sinonasal Tract LesionsGain of chromosome arm 1q in atypical meningioma correlates with shorter progression-free survival
P2860
Q26739662-45A3C8A3-0BA3-4B54-BDFF-D4276FD2BA95Q27022682-96D92DAE-335E-4D39-A702-DBB259AF1C7CQ27853347-61F59C12-552E-4CEC-981D-75A81B02E620Q28392585-670716B6-0FC6-496E-AB38-DA2552A17005Q28748900-49338B79-3C9A-4382-BB5F-745EF5C0AA44Q30356126-29D90D97-CF3D-4851-9F46-C7AD1D7F131AQ30379363-3D15A26B-55E0-427D-A2E8-77CAF99E21F3Q30461960-010BAD8B-ED54-4CBB-B230-49ED5EC6E1F4Q31003450-053D80F8-7A5A-4FF2-B9EA-3A674EE45551Q33212973-F181F8AC-6D9B-4BE1-9F7C-5E9136FE1428Q33272709-C802AC85-E43D-4C36-B5AB-91F07DD5F406Q33536079-F67A8314-9453-4007-BB74-D7B9A3A1F94AQ33754770-F06F6954-86C3-4E2F-A918-C65AA7A40A5AQ33760861-894916CE-6E18-42A1-BA8B-A6FF207E8407Q34324602-ED10FE5A-AA5C-4E6B-92C2-355612AB58C7Q34501813-BD27474E-D13B-4415-A345-397341948675Q34562612-8F81AAA6-7C8B-4110-808D-1B8526CDD3F8Q34806966-17FF86C4-5412-49FA-8B3C-1A4050488C42Q34980413-8A83C371-F171-44A7-ABFA-6ECBA94A7A9AQ35145251-9E00B030-049E-4221-B4D6-4A67838F0927Q35504767-3ED7C6B4-B21B-4931-98AA-CD145139CC7AQ35554222-B2715351-6180-4BDC-B3CC-463922F81895Q35584376-17BDC945-3CF0-4223-94B7-4BFD029279E4Q35741539-32718187-2E63-406C-9E57-0614009B547BQ35747010-FA2FAB04-2740-42C5-885B-1A8C5EA2F605Q35747646-9B72ED89-39C2-46B9-BEA8-7E3877C696F4Q35800821-4294C9FB-7338-4241-9664-B6B66C276F36Q35815316-C5E3777B-A829-445E-9F74-8A64D0622D0DQ35848234-6F7FFF55-EFEA-4658-B51E-D789076BD955Q35926564-68079D50-86EB-4317-A731-CDFFD59CBC54Q35943650-34ED07F0-8B3A-4F9F-84FB-117EB5731DA3Q35956175-B207DEEF-88B2-4D03-821F-EB40EB4B23E9Q35984427-16F7A2E8-FD46-4DA8-A72E-448FEFAD83F5Q36142117-50E1AF07-36ED-4202-9FB4-5A0DA437878AQ36177631-7899554C-3A54-4C11-982C-4E9B08A66F28Q36325372-D2443E04-2AD4-49CF-878E-D4A23FF2261CQ36483721-81BF799A-ACAD-4CB6-B863-E0ECBD29D27AQ36541821-A5FD4716-45A6-4294-9A89-2BCE675FB0D2Q36558594-03ECA33B-790A-461B-87D0-A73E4233A8C9Q36584592-2A07ABCB-E094-43F0-B8C7-C0E9F58910AF
P2860
"Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
"Malignancy" in meningiomas: a ...... ts, with grading implications.
@en
"Malignancy" in meningiomas: a ...... ts, with grading implications.
@nl
type
label
"Malignancy" in meningiomas: a ...... ts, with grading implications.
@en
"Malignancy" in meningiomas: a ...... ts, with grading implications.
@nl
prefLabel
"Malignancy" in meningiomas: a ...... ts, with grading implications.
@en
"Malignancy" in meningiomas: a ...... ts, with grading implications.
@nl
P2093
P2860
P1433
P1476
"Malignancy" in meningiomas: a ...... ts, with grading implications.
@en
P2093
Scheithauer BW
Stafford SL
P2860
P304
P356
10.1002/(SICI)1097-0142(19990501)85:9<2046::AID-CNCR23>3.0.CO;2-M
P407
P50
P577
1999-05-01T00:00:00Z